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Argonaute (AGO) proteins interact with small
RNAs to mediate gene silencing. C. elegans
contains 27 AGO genes, raising the question
of what roles these genes play in RNAi and
related gene-silencing pathways. Here we de-
scribe 31 deletion alleles representing all of
the previously uncharacterized AGO genes.
Analysis of single- and multiple-AGO mutant
strains reveals functions in several pathways,
including (1) chromosome segregation, (2) fer-
tility, and (3) at least two separate steps in the
RNAi pathway. We show that RDE-1 interacts
with trigger-derived sense and antisense RNAs
to initiate RNAi, while several other AGO pro-
teins interact with amplified siRNAs to mediate
downstreamsilencing.Overexpression of down-
stream AGOs enhances silencing, suggesting
that these proteins are limiting for RNAi. Inter-
estingly, these AGO proteins lack key residues
required for mRNA cleavage. Our findings
support a two-step model for RNAi, in which
functionally and structurally distinct AGOs act
sequentially to direct gene silencing.
INTRODUCTION
The term RNA interference (RNAi) was initially coined to
describe a gene-silencing mechanism induced by the ex-
perimental introduction of RNA into the nematode
C. elegans (Rocheleau et al., 1997; Fire et al., 1998). Sub-sequent work in numerous organisms revealed that key
steps in the RNAi pathway are shared by a diverse and
truly remarkable set of endogenous gene regulatory
mechanisms (for review see Zamore and Haley, 2005).
Among others, these include mechanisms that downregu-
late endogenous genes and restrain the expression of
selfish or exogenous genetic material, mechanisms that
direct transcriptional gene silencing and alter chromatin
to promote kinetochore function and chromosome segre-
gation, and, perhaps most remarkable of all, a mechanism
in Tetrahymena, in which the genomic content of nuclei are
compared within a shared cytoplasm prior to chromatin
modification and targeted DNA elimination. The term
RNAi is often used now to refer to the shared portion of
all of these diverse pathways.
During RNAi, members of the Dicer family of proteins
process dsRNA to initiate gene silencing (reviewed in
Carmell and Hannon, 2004). Dicer can process dsRNAs
derived from either exogenous or endogenous sources,
generating small interfering (si)RNAs of approximately 21
nucleotides that guide sequence-specific silencing (for re-
view see Simard and Hutvagner, 2005). In addition to pro-
cessing dsRNA substrates, Dicer copurifies with a large
complex that loads the siRNAs into the RNA-induced
silencing complex (RISC) (Liu et al., 2003; Pham et al.,
2004; Tomari et al., 2004; Chendrimada et al., 2005;).
Several studies, including recent elegant structural and
functional studies, suggest that members of the AGO pro-
tein family are key components of RISC (Liu et al., 2004;
Meister et al., 2004; Song et al., 2004). In C. elegans, the
AGO protein RDE-1 is required for silencing in response
to experimentally introduced dsRNA (Tabara et al.,
1999). AGO proteins have also been implicated in gene si-
lencing in fungi, plants, protozoans, and metazoans in-
cluding humans (reviewed in Carmell et al., 2002). MostCell 127, 747–757, November 17, 2006 ª2006 Elsevier Inc. 747
organisms have multiple members of the AGO protein
family, and several studies suggest that these proteins
are specialized to perform distinct functions. For example,
two closely related C. elegans AGO proteins, ALG-1 and
ALG-2, are not required for silencing in response to exog-
enous (exo) or transgene-derived dsRNA but are essential
for the processing and function of the Dicer-derived, de-
velopmentally important small RNA species termed
microRNAs (miRNAs) (Grishok et al., 2001).
Biochemical studies indicate that AGO proteins interact
with Dicer (Hammond et al., 2001; Chendrimada et al.,
2005; Tabara et al., 2002) and that small RNAs generated
by Dicer are loaded directly onto AGO proteins to form ac-
tive RISC (reviewed in Filipowicz, 2005). Once charged
with a small RNA, AGO proteins are thought to mediate
the target-sensing and effector steps in all RNAi-related
mechanisms. Two distinct RNA binding domains in AGO
proteins, the PAZ (Piwi/Argonaute/Zwille) and PIWI do-
mains, appear to facilitate interactions with the 30 and 50
termini (respectively) of the small single-stranded RNA
guides, leaving internal nucleotides available for base
pairing (reviewed in Song and Joshua-Tor, 2006). Upon
target recognition, base-pairing interactions and helix
formation are predicted to place the phosphodiester
backbone of the target RNA in proximity to the catalytic
center of the RNase H-related PIWI domain. In the case
of siRNA RISC (siRISC), this interaction is thought to
lead directly to target mRNA cleavage. In other RISC com-
plexes, such as the majority of miRISC complexes in ani-
mals, helix formation is interrupted by imperfect base pair-
ing, preventing direct cleavage of the target RNA and
allowing other forms of regulation, such as inhibition of
mRNA translation.
Here we show that AGO proteins not only function in
several different pathways in C. elegans but that, surpris-
ingly, distinct AGOs function sequentially during RNAi.
Our findings support a model in which the RDE-1 protein
engages siRNAs derived from Dicing of the trigger dsRNA
(primary siRNAs), while a set of several other AGO proteins
interact with siRNAs that are amplified during the silencing
process (secondary siRNAs). Overexpression of the
downstream (or secondary) AGO proteins causes the ac-
cumulation of high levels of siRNAs and results in animals
that are hypersensitive to RNAi. These findings suggest
that secondary AGO protein levels are limiting for RNAi
in C. elegans. The secondary AGO proteins lack key
metal-coordinating residues in their RNase H-related
PIWI domains, perhaps explaining why siRISC-mediated
cleavage activity has not been detected to date in
C. elegans. Finally, we provide evidence that endogenous
(endo)-RNAi pathways also utilize AGO proteins at two
steps and appear to converge on the same secondary
AGOs that function in the exogenous dsRNA-induced, or
exo-RNAi, pathway. In summary, our findings point to di-
verse roles for AGO proteins in C. elegans and support an
AGO-relay mechanism involving structurally and function-
ally distinct AGOs that act sequentially during the initiation
and effector steps of RNAi.748 Cell 127, 747–757, November 17, 2006 ª2006 Elsevier IncRESULTS
RDE-1 Interacts with Trigger-Derived
Single-Stranded RNA
Genetic and biochemical studies place the C. elegans
AGO protein RDE-1 at an upstream step in the RNAi path-
way (Grishok et al., 2000; Tabara et al., 2002). To ask if
RDE-1 interacts with siRNAs derived directly from the pro-
cessing of the exo-trigger dsRNA, which are present at
very low levels (Parrish et al., 2000), we utilized a sensitive
assay that employs a 20-O-methylated RNA affinity matrix
to trap sequence-specific AGO/siRNA-mediated RNA
binding events (Hutvagner et al., 2004). When whole ani-
mal lysates are exposed to this matrix, siRNA protein
complexes are able to interact with the 20-O-methylated
RNA through sequence-specific base pairing but are un-
able to cleave the modified RNA backbone and are there-
fore retained on the affinity matrix (see Figure 1A).
We found that, after exposure of animals to dsRNA, the
RDE-1 protein exhibits sequence-specific interactions
with both the sense and antisense 20-O-methylated RNA
matrices. These interactions were specific for the trigger
dsRNA sequence to which the animals were exposed
(Figure 1B). This interaction was not detected when ani-
mals were exposed to the bacterially expressed dsRNA
trigger for 1 hr or less (Figure 1C), suggesting that internal-
ization and processing of the trigger dsRNA in the animal
is required to form an RDE-1 complex capable of
sequence-specific binding to the affinity matrix.
Consistent with processing of the original dsRNA trigger
into single-stranded guide RNAs, we found that pretreat-
ment of the extracts with the single-stranded ribonucle-
ases RNase A/T1, but not with the dsRNA-specific nucle-
ase RNase V1, dramatically reduced the interaction of
RDE-1 with the 20-O-methyl target RNA matrices (Fig-
ure 1D). The sequence-specific retention of RDE-1 on
the 20-O-methylated matrices occurred with similar effi-
ciency regardless of whether a target mRNA was ex-
pressed in the strain (Figure 1E, compare lanes 1 and 2).
To further analyze the step at which RDE-1 functions in
RNAi, we tested the binding of the RDE-1 protein to the 20-
O-methyl matrices in various RNAi-deficient mutant back-
grounds. In the strong loss-of-function sid-1(ne328) mu-
tant, which has defects in dsRNA uptake and systemic
transport to tissues in the body (Winston et al., 2002),
RDE-1 exhibited a markedly reduced interaction with the
20-O-methyl target sequences (Figure 1E, lane 4). In con-
trast, in an RNAi-deficient, multiple-AGO mutant (MAGO)
strain (described below) and in a strain deficient in rrf-1
that encodes an RNA-dependent RNA polymerase
(RdRP)-related protein that is thought to amplify the si-
lencing signal (Smardon et al., 2000; Sijen et al., 2001;
Conte and Mello unpublished), the RDE-1 protein was still
recruited to the 20-O-methyl matrices (Figure 1E, lanes 5
and 6). These findings support the placement of RDE-1
downstream of the systemic transport of dsRNA into tis-
sues and upstream of the amplification of the silencing
signal..
RDE-1 Does Not Interact with Secondary siRNAs
During RNAi in C. elegans the target mRNA appears to
serve as a template for the RdRP-dependent amplification
of the silencing signal (Sijen et al., 2001). The secondary
siRNAs produced through this amplification process are
abundant enough to detect by northern blot analysis and
consist of the antisense polarity only (Grishok and Mello
Unpublished; Sijen et al., 2001).
To ask whether RDE-1 interacts with these amplified
secondary siRNAs we exposed animals to dsRNA and ex-
amined RDE-1 immune complexes for associated small
RNAs by northern blot analysis. For this analysis we tar-
geted a green fluorescent protein (GFP)-transgenic strain
that produces abundant and easily detected secondary
siRNAs after exposure to GFP dsRNA. In these studies,
neither sense nor antisense siRNAs were detected in
RDE-1 immunoprecipitates (data not shown). To ask if
low levels of the siRNAs corresponding to the amplified re-
gion interact with RDE-1, we used sense and antisense 20-
O-methyl matrices complementary to GFP sequences
Figure 1. Sequence Specificity and Genetics of RDE-1/RNA
Affinity Matrix Binding
(A) Schematic representation of the strategy used to recover proteins
interacting with low-abundance (primary) siRNAs.
(B)–(E) Western blot analysis to detect HA::RDE-1 (B–D) or endoge-
nous RDE-1 protein (E) in lysates prepared from worms treated as dia-
grammed in (A), using nonoverlapping 40 nt segments of GFP as
dsRNA triggers. In (B) RDE-1 exhibits sequence-specific interactions
with the 20-O-methyl matrices. In (C) the association of RDE-1 with trig-
ger-derived RNA requires prolonged exposure of worms to the
dsRNA-expressing E. coli. Animals were either not exposed to E.
coli-expressing dsRNA (0 hr) or were allowed to feed on the E. coli
for 1 hr or 48 hr as indicated. In (D) the RDE-1 interaction with the 20-
O-methyl matrix depends on single-stranded RNA. Prior to exposure
to the affinity matrix, worm lysates were pretreated with either the
dsRNA-specific nuclease RNase V1 (V1) or with the single-stranded
RNA-specific nucleases RNase A and RNase T1 (A&T1). Under these
conditions, unmodified control RNAs were totally degraded, while
the 20-O-methyl modified oligonucleotides were unaffected (data not
shown, Tabara et al., 2002; Sproat et al., 1989). In (E) genetic analysis
of RDE-1 affinity-matrix binding is shown. dsRNA triggers and 20-O-
methyl affinity matrices were prepared using a 40 nt region of the
unc-22 gene that is deleted in unc-22(st528), a functionally wild-type
allele that harbors an in-frame deletion. The RNAi-deficient mutant
strains analyzed are unc-22(st528), rde-1(ne300), sid-1(ne328), and
rrf-1(pk1417).Clocated 50 of the region targeted by the dsRNA trigger (re-
gions p2 and p1 in Figure 2A). After triggering RNAi with
dsRNA targeting region p3, we confirmed by northern
blot analysis that secondary siRNAs could be detected
with a probe derived from region p2 (Figure 2B). Although
RDE-1 was readily recovered on the 20-O-methyl matrix
corresponding to the trigger, RDE-1 was not recovered
on the 20-O-methyl matrix corresponding to the upstream
region, region p2 (Figure 2C, top panel). When RNAi was
initiated using a trigger dsRNA targeting region p2, we
found that RDE-1 was readily recovered on the region-
p2-specific affinity matrix (Figure 2C, bottom panel), dem-
onstrating that the p2 matrix is functional. These data sug-
gest that the RDE-1 protein only interacts with the very low
abundance primary siRNAs and not with the much more
abundant secondary siRNAs derived from the amplifica-
tion process.
Genetic Analysis of AGO Mutants in C. elegans
Since RDE-1 does not appear to interact with secondary
siRNAs, we reasoned that one or more of the numerous
RDE-1 homologs in the C. elegans genome might play
this downstream role in the RNAi pathway. The C. elegans
genome contains a set of 27 annotated AGO-related
genes (Figure 3A). To begin to assign functions to these
genes we first used RNAi to target each gene for silencing.
In addition, we generated deletion alleles for all of these
genes except for rde-1 and alg-2, for which alleles were
already available (see Figure S1).
The two most highly conserved members of the
C. elegans AGO family, alg-1 and alg-2, have overlapping
functions in the miRNA pathway and are essential for de-
velopment (Grishok et al., 2001). Our analysis revealed
that two additional AGOs, F20D12.1, which we have re-
named csr-1, and prg-1 are also essential for develop-
ment. Depletion of csr-1 by RNAi resulted in penetrant
Figure 2. RDE-1 Does Not Interact with Secondary siRNAs
(A)–(C) Schematic representation of the GFP transcript, showing the
relative positions of targeted regions. The dsRNA triggers and 20-O-
methyl affinity matrices were prepared as described in Figure 1A, using
sequences corresponding to the three 40 nt regions of GFP indicated
in the diagram. Lysates prepared from GFP-transgenic animals ex-
posed to the dsRNA triggers (p2 and p3) were used for (B) northern
blot analysis of small RNA species, and (C) Western blot analysis for
RDE-1 protein after exposure to affinity matrices (as indicated). In (B)
the RNA probe used was derived from region p2. Note that small
RNAs corresponding to region p2 are detected even when region p3
is used as the trigger.ell 127, 747–757, November 17, 2006 ª2006 Elsevier Inc. 749
Figure 3. AGO Genes Are Required for RNAi and Development
(A) Phylogenetic tree of representative AGO proteins from plants, animals, and fungi. The AGO group with representatives in all three kingdoms is
indicated in black and the PIWI group common to all metazoans is indicated in green. An expanded group ofC. elegans proteins about equally distant
from the PIWI and AGO subgroups is shown in red. ClustalW was used for the alignment, and the tree was created by bootstrapping and neighbor-
joining methods using Phylip software. Ce (Caenorhabditis elegans), At (Arabidopsis thaliana), Hs (Homo sapiens), Sp (Schizosaccharomyces
pombe).
(B) csr-1/F20D12.1 is required for chromosome segregation. Histone- and tubulin-GFP fluorescence images of wild-type and csr-1/F20D12.1(RNAi)
embryos at anaphase of the first cell division.
(C) ergo-1(tm1860) exhibits enhanced RNAi. The broods of between seven and ten animals (80 embryos per animal) were scored per genotype, and
the percent of embryos sensitive to RNAi targeting the hmr-1 E-cadherin gene is shown. Expression of wild-type ERGO-1 from a transgene (ergo-1
rescue) partially restores resistance to RNAi. Failure to see a more robust rescue may reflect the poor expression of the ergo-1(+) high-copy number
transgene in the germline.
(D and E) Multiple red-clade AGOs contribute to RNAi. For germline RNAi, nine to ten animals were exposed to pos-1(RNAi) by feeding, and the per-
cent pos-1 embryonic lethal embryos produced is shown (orange bars). For somatic RNAi, between four and ten animals were injected with 20 mg/ml
unc-22 dsRNA (D) or with 1 mg/ml unc-22 dsRNA (E), and the percent paralyzed progeny (black bars) or twitching but motile progeny (green bars) are
shown. The error bars (C–E) represent the 95% confidence interval.embryonic lethality with defects in the organization of
chromosomes at metaphase of each early embryonic
cell cycle and the formation of anaphase DNA bridges
(Figure 3B and data not shown). Most csr-1 deletion ho-
mozygotes are sterile, but some hermaphrodites produce
a few embryos with chromosome segregation defects
identical to those observed in csr-1(RNAi) embryos. The
csr-1 mutant is also partially deficient in germline RNAi
(see Figures S2A and S2B). Thus csr-1 defines a new
gene class, csr (pronounced ‘‘caesar’’), whose members
exhibit loss-of-function phenotypes with defects in both
chromosome segregation and RNAi. A mutation in prg-
1(tm872), a member of the metazoan-specific Piwi sub-
family of AGO genes, exhibited a reduced brood size
and a temperature-sensitive sterile phenotype (Fig-
ure S2C), consistent with previous findings linking prg-1
to germline maintenance (Cox et al., 1998).750 Cell 127, 747–757, November 17, 2006 ª2006 Elsevier Inc.A single mutant, R09A1.1, which we have renamed
ergo-1 for endogenous RNAi-deficient Argonaute mutant,
exhibited an enhanced sensitivity to RNAi (Figure 3C). This
enhanced RNAi phenotype was partially rescued by the
introduction of an ergo-1 wild-type transgene, supporting
the idea that the enhanced RNAi phenotype is due to
a loss of ergo-1 activity (Figure 3C). As implied by its
name, ergo-1 activity is required for an endo-RNAi path-
way (see below).
Multiple AGOs Contribute Incrementally to RNAi
We assayed each viable AGO mutant allele for sensitivity
to RNAi. We also used a sequential RNAi assay to search
for potential involvement of each AGO in RNAi (see
Figure S2D). These assays defined ppw-1 (also observed
in Tijsterman et al., 2002) and F58G1.1 as partially defi-
cient in RNAi. These two genes represent divergent
members of an expanded clade of AGOs present in
C. elegans (Figure 3A, red branches). To more carefully ex-
amine the activities of the other members of this clade, we
analyzed mutant alleles of these genes using a more sen-
sitive microinjection assay optimized for detecting defi-
ciencies in RNAi.
In this more sensitive assay we targeted the muscle-
specific unc-22 gene and set the dose of dsRNA for micro-
injection at 20 mg/ml, which is sufficient to induce approx-
imately 50% paralyzed and 50% motile twitching animals
after injection into wild-type animals. These assays re-
vealed that while two mutants, ppw-1 and F58G1.1,
were partially deficient in germline RNAi (Figure 3D, or-
ange bars), four mutants, K12B6.1, F56A6.1, C04F12.1,
and F58G1.1, were partially deficient in RNAi targeting
the somatic gene unc-22 (Figure 3D, green and black
bars). For reasons described below, we have renamed
K12B6.1 and F56A6.1 sago-1 and sago-2, respectively.
We next examined the consequences of creating a mul-
tiple mutant including alleles of four genes implicated in
RNAi by their single mutant phenotypes (ppw-1, sago-1,
sago-2, and F58G1.1). In this MAGO strain we also in-
cluded alleles of two additional genes, C06A1.4, a close
homolog of F58G1.1, and M03D4.6, a close homolog of
sago-2 and ppw-1. Both C06A1.4 and M03D4.6 are now
predicted to be pseudogenes and, perhaps consistent
with this designation, their inclusion in multiple mutant
strains did not appear to result in any enhancement of the
RNAi defect in our assays (see Figure S3A). The MAGO
strain, comprised of the ppw-1(tm914), sago-1(tm1195),
sago-2(tm894), F58G1.1(tm1019), C06A1.4(tm887), and
M03D4.6(tm1144) alleles, was resistant to both germline
and somatic RNAi (Figure 3D). This strain was still weakly
sensitive to RNAi in response to injected dsRNA at concen-
trations of 1 mg/ml (Figure 3E). Nevertheless, this strain
was strongly deficient in RNAi by feeding and was suitable
for the functional studies described below. The MAGO
strain also exhibits a temperature-dependent reduction
in fertility when cultured at 25C but has no other easily dis-
cernable phenotypes (data not shown).
AGOs Required for RNAi Exhibit Qualitatively
Distinct Activities
To compare the activities of AGO genes, we performed
rescue assays in which we used the potent muscle-spe-
cific myo-3 promoter to overexpress individual AGOs in
the muscles of the rde-1 and MAGO strains. Consistent
with the idea that RDE-1 and the MAGO components
are not interchangeable, we found that overexpression
of RDE-1 rescued the rde-1 mutant but failed to rescue
RNAi in the MAGO strain (Figure 4A). Conversely, overex-
pression of wild-type or GFP-tagged alleles of the MAGO
components, sago-1, sago-2, and ppw-1, strongly res-
cued the MAGO strain but failed to rescue the RNAi defect
of the rde-1 mutant strain (Figure 4A). These findings sug-
gest that sago-1, sago-2, and ppw-1 encode functionally
interchangeable proteins whose overexpression can
compensate for the collective RNAi defect of the MAGOCstrain. RDE-1, on the other hand, appears to have a quali-
tatively distinct activity. We also attempted to rescue the
rde-1 and MAGO strains using other AGO family mem-
bers. The microRNA-AGO alg-1, as well as prg-1 and
csr-1, failed to rescue either rde-1 or the MAGO strain
(Figure 4A).
SAGO-1 and SAGO-2 Interact with Secondary
siRNAs
The findings that at least three AGOs, SAGO-1, SAGO-2,
and PPW-1, appear to differ functionally from RDE-1 in
our muscle-specific rescue assays prompted us to ask
whether these AGOs might interact with secondary
siRNAs. To address this question, northern blot analysis
Figure 4. GFP::SAGO-1 and GFP::SAGO-2 Rescue the MAGO
Strain and Interact with Secondary siRNAs
(A) Rescue of the RNAi-deficient phenotypes of the rde-1 and MAGO
strains via myo-3-promoter-driven expression of AGO genes (as indi-
cated). Transgenic animals were cultured on unc-22 dsRNA-express-
ing bacteria. Animals were scored for the unc-22(RNAi) phenotype.
The (+) indicates Unc (RNAi-responsive) animals while () indicates
NonUnc (RNAi-deficient) animals. One hundred percent of the animals
scored (n) showed the indicated phenotype.
(B) Schematic diagram indicating the regions within the unc-22 gene
used to prepare RNA probes.
(C and D) Northern blot analysis of small RNAs in (C) GFP::AGO im-
mune complexes and (D) total lysates. The strains and probes are as
indicated; the dsRNA trigger was derived from region p2. The lower
panel in (C) is a western blot probed with a GFP-specific monoclonal
antibody. In (D) the RNAi-deficient alleles analyzed are rde-1(ne300)
and rrf-1(pk1417); the 5S ribosomal RNA is shown as a loading control.
In the upper panel of (D) the p1-specific probe is a Starfire probe com-
prised of a 40 nt segment of region p1.ell 127, 747–757, November 17, 2006 ª2006 Elsevier Inc. 751
was performed to detect small RNAs associated with
GFP-tagged SAGO-1 and SAGO-2. Indeed, secondary
siRNAs derived both from within the trigger region (Fig-
ure 4B, probe p2) and from the region upstream of the trig-
ger dsRNA (Figure 4B, probe p1) were detected in GFP-
immune complexes recovered from the corresponding
MAGO-rescued strains (Figure 4C, lanes 1 and 2). We
did not detect siRNAs using a probe located just down-
stream (30) of the trigger dsRNA (probe p3 in Figure 4B
and data not shown), and we did not detect sense siRNAs
associated with these immune complexes using probes
from any of the three regions (p1, p2, or p3, data not
shown).
Interestingly, we noticed that strains overexpressing
GFP::SAGO-1 exhibited an enhanced level of RNAi over-
all. For example, 100% (n = 49), of the myo-3p::GFP::
SAGO-1 transgenic animals exhibited a paralyzed unc-
22 RNAi phenotype, whereas wild-type animals failed to
exhibit paralyzed twitchers and were instead strong, but
still motile, twitchers after 36 hr of exposure to unc-22
RNAi (n = 54).
Consistent with the increased level of silencing in these
strains, we found that the levels of secondary siRNAs were
substantially increased relative to wild-type levels in
strains overexpressing SAGO-1 (Figure 4D, compare
lanes 3 and 5). The overaccumulation of siRNAs was
less evident in the GFP::SAGO-2 transgenic strain (Fig-
ure 4D, compare lanes 3 and 6). This appears to reflect rel-
atively weaker expression from the GFP::SAGO-2 trans-
gene (see western blot, lower panel in Figure 4C). As
expected from previous studies (Grishok and Mello un-
published, Sijen et al., 2001), only siRNAs of the antisense
polarity were detected in these assays (data not shown).
Taken together the findings (1) that mutations in sago-1
and sago-2 lead to reduced RNAi activity, (2) that these
mutations appear to disrupt RNAi downstream of the in-
teraction of RDE-1 with primary siRNAs, (3) that overex-
pression leads to increased RNAi activity and to the res-
cue of secondary siRNA levels, and (4) that the rescuing
proteins coimmunoprecipitate with secondary siRNAs,
strongly support the notion that at least these two AGOs
(and likely others) interact with and stabilize secondary
siRNAs to direct silencing during RNAi.
Consistent with the idea that RDE-1 is functionally
distinct from these AGOs, we found that although HA::
RDE-1 fully rescues the RNAi defect of rde-1(ne300), its
overexpression does not lead to any observable increase
in secondary siRNA levels (Figure 4D, lane 7) and does not
result in any detectable interaction between HA::RDE-1
and secondary siRNAs (data not shown). Finally, consistent
with the placement of SAGO-1 and SAGO-2, either at the
same step or downstream of RdRP-dependent second-
ary-siRNA production, we found that overexpression of
SAGO-2 failed to rescue the RNAi-deficient phenotype
of an rrf-1/RdRP mutant strain (data not shown) and, as
expected, also failed to rescue secondary siRNA accumula-
tion in the rrf-1 mutant background (Figure 4D, top panel,
lane 8).752 Cell 127, 747–757, November 17, 2006 ª2006 Elsevier Inc.Based on the strong genetic and physical criteria linking
sago-1 and sago-2 to secondary siRNAs, we propose to
define this gene class as sago (pronounced ‘‘say-go’’),
for synthetic secondary-siRNA defective AGO mutants.
This class of AGOs is likely to include ppw-1, a close ho-
molog of sago-1 and sago-2, as well as other members
of the expanded clade of AGO genes in C. elegans (see
Figure 3A and Discussion).
An Endogenous Small RNA Pathway Requires
ERGO-1 and the SAGO Proteins
The finding that increasing the levels of the SAGO proteins
increases RNAi activity suggests that these AGOs are
present in limited supply. In C. elegans, silencing in re-
sponse to exogenous, experimentally delivered dsRNA
(exo-RNAi) is increased when certain endo-RNAi path-
ways are compromised by mutation (Duchaine et al.,
2006; Lee et al., 2006). These findings suggest that the
exo-RNAi and endo-RNAi pathways may converge on,
and compete for, an unknown limiting factor shared by
both pathways. Because the SAGO proteins are limiting
for exo-RNAi we wondered if they might encode compo-
nents of this shared limiting activity. Consistent with this
idea, we found that siRNAs derived from an endogenous
C. elegans gene, K02E2.6, and from an apparently non-
coding X chromosome cluster are both reduced in the
MAGO strain (Figures 5A and 5B).
Expression of GFP::SAGO-1 and GFP::SAGO-2 in the
muscles of MAGO animals rescued the accumulation
of the X-cluster and K02E2.6 endo-siRNA species
(Figure 5B). As with the secondary exo-siRNAs (see
Figure 5. ergo-1(tm1860) and the MAGO Strain Are Deficient
in Endo-siRNA Expression
(A and B) Northern blot analysis of endogenous small RNAs in wild-
type and various mutant and transgenic rescued strains, as indicated.
The 5S ribosomal RNA blots are provided as loading controls. In (A) the
RNAi-deficient alleles analyzed are rde-1(ne300) and ergo-1(tm1860).
(C) Immunoprecipitation (IP)-northern blot analysis (top two panels)
and IP-western blot analysis (bottom panel) of GFP-immune com-
plexes recovered from rescuing GFP::SAGO-1 and GFP::SAGO-
2 transgenic strains. Probes for the K02E2.6 and the X-cluster endo-
siRNAs and for the let-7 miRNA are described in Duchaine et al. (2006).
Figure 6. Model
Schematic representations of RNAi-related pathways inC. elegans. Exo- and endo-RNAi pathways are proposed to involve sequential rounds of AGO
action involving primary siRNA containing AGO complexes (gray ovals), and secondary siRNA containing AGO complexes (colored ovals). The miRNA
pathway is proposed to involve a single AGO-mediated step. Distinct DCR-1 complexes are proposed to recognize the dsRNA substrates illustrated
in the diagram. Evidence exists for several of these complexes, including the ALG, RDE-1, ERI, and PIR-1 containing DCR complexes (Tabara et al.,
2002; Duchaine et al., 2006). After primary-siRNA-directed cleavage, a protein complex potentially containing RDE-3 (Chen et al., 2005, pink object) is
proposed to mark the 30 end of the 50 cleavage product and to recruit RdRP. The question marks and dashed lines indicate speculative elements in the
model.Figure 4C), these endo-siRNA species accumulate to
levels that are higher than wild-type levels in strains over-
expressing these AGOs (Figure 5B). Note that the level of
endo-siRNA accumulation correlates with the level of
SAGO-protein expression as measured in the western blot
(Figure 5B, lower panel). Like the secondary exo-siRNAs,
we found that the endo-siRNAs also coimmunoprecipitate
with GFP::SAGO-1 and GFP::SAGO-2 (Figure 5C).
Interestingly, endo-siRNA levels were even more dra-
matically reduced in ergo-1(tm1860) AGO mutant animals
(Figure 5A, lane 2), in which exo-RNAi is enhanced (see
Figure 3C and Discussion). Furthermore, consistent with
competition between the ERGO-1 and RDE-1 pathways,
the levels of K02E2.5 endo-siRNAs were increased in an-
imals deficient for rde-1 (see Figure 5A and Discussion).
There were no significant changes in the level of let-7
miRNA expression in these strains (Figure 5A). Expression
of a partially rescuing ergo-1(+) transgene in the ergo-
1(tm1860) mutant strain partially restored the expressionCof the X-cluster-derived endo-siRNA species (Figure 5A,
right panel).
DISCUSSION
Through a combination of forward genetics, reverse ge-
netics, and proteomics, we have arrived at a model
for RNAi (Figure 6) that explains how multiple, small
RNA-mediated silencing pathways interact with each
other and converge on shared components of the RNAi
machinery. This model explains how RNA-silencing path-
ways can achieve both specificity and amplification. Ac-
cording to this model, upon exposure to E. coli expressing
dsRNA, intestinal cells take up and disseminate small
quantities of dsRNA to other tissues via a systemic mech-
anism that depends in part on the SID-1 channel protein
(Feinberg and Hunter, 2003; Winston et al., 2002). The
dsRNA is then processed by a Dicer complex that in-
cludes the dsRNA binding protein RDE-4 and the AGOell 127, 747–757, November 17, 2006 ª2006 Elsevier Inc. 753
protein RDE-1 (Tabara et al., 2002). A scanning phase of
RNAi follows, in which RDE-1/primary-siRNA complexes
search for target mRNA sequences. RDE-1 then recruits
RdRP, perhaps indirectly through an initial round of target
mRNA cleavage. This initial targeting by RDE-1 is suffi-
cient to initiate amplification but insufficient, by itself, to
cause silencing (due to the low levels of the primary
siRNAs).
The target mRNA is proposed to act as a template for
the primer-independent synthesis of new dsRNA (see
also Duchaine et al., 2006). RdRPs related to those in-
volved in RNAi have been shown to catalyze primer-inde-
pendent RNA synthesis (Makeyev and Bamford, 2002).
Recruitment of RdRP directly to the target mRNA, without
the need for priming, would permit new dsRNA synthesis
without consuming the original trigger-derived siRNAs.
This process would allow each of the rare RDE-1/siRNA
complexes to be recycled to target multiple transcripts
and would thus permit multiple rounds of RdRP-depen-
dent amplification. According to this model, a second
Dicer complex would then act to process the RdRP prod-
ucts and to load the amplified secondary siRNAs onto
members of a group of partially redundant secondary
AGOs that include SAGO-1, SAGO-2, and likely other
related proteins.
The RDE-1 and the SAGO proteins exhibit structural dif-
ferences that may help explain their distinct biological ac-
tivities. An alignment of members of the AGO protein fam-
ily reveals that most members of this family, including
RDE-1 and ERGO-1, exhibit conservation of key metal-
coordinating residues in the RNase H-related PIWI domain
(D,D, and H residues in Figure 7). SAGO-1, SAGO-2, and
several other members of the expanded C. elegans AGO
clade (red branches in Figure 3A), including the other com-
ponents of the RNAi-deficient MAGO strain (Figure 7, blue
shaded sequences), conspicuously lack these residues.
Thus, while RDE-1 might be expected to retain catalytic
activity, the SAGO proteins would very likely require ac-
cessory factors to mediate target mRNA turnover (model,
Figure 6).
The model for RNAi proposed above provides two op-
portunities for amplification. First the RDE-1/siRNA com-
plex, although low in abundance, is proposed to work
repeatedly to generate multiple templates for RdRP. Sec-
ond, Dicer is proposed to process each RdRP-derived
dsRNA product into several secondary siRNAs. Acting to-
gether, these two steps ([1] repeated mRNA targeting by
the RDE-1/primary-siRNA complex, followed by [2]
RdRP-dependent dsRNA synthesis and Dicer processing)
could generate potentially thousands of secondary siRNA
for each original primary siRNA.
While amplification of the silencing signal would have
obvious benefits for suppressing viral gene expression,
this is balanced against a danger of amplifying off-target
silencing. Conceivably, any off-target cleavage events
mediated by the primary-siRNA/RDE-1 complex could
lead to a chain reaction of silencing with obvious deleteri-
ous consequences. The model for silencing proposed754 Cell 127, 747–757, November 17, 2006 ª2006 Elsevier Inc.here could safeguard against off-target amplification in
three ways. First, since RDE-1 does not need to silence
the target mRNA by itself, the target-scanning step medi-
ated by RDE-1 can afford to incorporate a very high de-
gree of selectivity. Second, since the downstream AGOs
lack catalytic residues required for mRNA cleavage, they
may be unable to generate cleaved substrates for further
amplification. And finally, the downstream AGO proteins
are present in limited supply and thus provide limited
capacity to support multiple simultaneous silencing
reactions.
Perhaps consistent with the idea that safeguards exist
to prevent the initiation of off-target silencing, the injection
of concentrated dsRNA, or even the promoter-driven ex-
pression of dsRNA, cannot bypass the requirement for
rrf-1, the RdRP required for amplification. Furthermore, al-
though we have shown that RDE-1 still appears to interact
with primary siRNAs in rrf-1 mutants, neither the primary
nor the secondary siRNAs are detectable in rrf-1 mutants,
even in the presence of abundant promoter-driven dsRNA
(Sijen et al., 2001; Conte and Mello, unpublished). These
results suggest that the processing of trigger dsRNA and
loading into the RDE-1 complex may be inherently ineffi-
cient. Alternatively, mechanisms may exist that function
to limit the formation of the RDE-1/primary-siRNA com-
plex, even in the presence of large quantities of trigger
dsRNA. Such mechanisms could be important to limit
the pioneering round of target recognition by RDE-1 and
Figure 7. Secondary AGOs Lack Key Catalytic Residues
Alignment of C. elegans AGO proteins in three regions with similarity to
the catalytic center of RNase H. Within these regions two key aspartic
acid residues (highlighted in red) and a histidine residue (highlighted in
dark blue) coordinate a magnesium ion at the catalytic center of the
RNase H enzyme. Substitutions compatible with metal binding are in-
dicated in orange. The RDE-1 and ERGO-1 amino-acid sequences are
highlighted in shades of green, while those of the MAGO strain compo-
nents are highlighted in blue.
thus to minimize the risk of amplifying off-target silencing
reactions.
Intersecting RNAi Pathways in C. elegans
Several of our findings suggest that ERGO-1 may function
in the endo-RNAi pathway in a manner analogous to the
role of RDE-1 in the exo-RNAi pathway. Furthermore,
our findings support the hypothesis that the ERGO-1
and RDE-1 pathways converge on the SAGO proteins
(Figure 6). Consistent with this model, the MAGO strain,
which includes lesions in sago-1 and sago-2, exhibits de-
fects in both secondary siRNA accumulation and in the ac-
cumulation of endo-siRNA species. The convergence of
several pathways on members of the secondary group
of AGOs may provide selective pressure for the mainte-
nance of this amplified gene family.
ERGO-1 is required for endo-siRNA accumulation, and
lesions in ergo-1 enhance exo-RNAi. These findings sup-
port the placement of ERGO-1 upstream of the conver-
gence between the endo- and exo-RNAi pathways in the
model (Figure 6). Accordingly, while mutations in ergo-1
prevent the accumulation of endo-siRNAs, they do not in-
terfere with exo-siRNA production. Instead, by eliminating
an abundant endo-siRNA species that would otherwise
compete with exo-siRNAs for loading onto the limiting
SAGO proteins, lesions in ergo-1 enhance the exo-RNAi
pathway (Figure 6).
The ERI proteins and the RdRP RRF-3 may function
along with ERGO-1 in the production of endo-siRNAs (Fig-
ure 6 and Duchaine et al., 2006). ERGO-1 has a potentially
intact catalytic domain and in this respect is structurally
similar to RDE-1 (Figure 7). Conceivably, low levels of
dsRNA synthesis from endogenous loci could provide
precursors for the production of primary endo-siRNAs
that are loaded onto ERGO-1. ERGO-1, through RNA-
scanning, target cleavage, and RRF-3-recruitment, may
then direct the accumulation of abundant secondary
endo-siRNA species that interact with, and compete for,
the SAGO proteins.
AGOs and Transcriptional Gene Silencing
Transcriptional silencing appears to be an important mode
of RNAi-directed silencing in C. elegans. While this has
been best studied in fungi (reviewed in Grewal and Rice,
2004), elements of a transcriptional silencing pathway ex-
ist in a variety of organisms (Reviewed in Wassenegger,
2005). In C. elegans, transgene silencing and cosuppres-
sion, which are maintained in part by chromatin-related si-
lencing pathways (Tabara et al., 1999; Ketting et al., 1999;
Grishok et al., 2005; Robert et al., 2005), require a subset
of the genes implicated in exo-dsRNA-induced RNAi.
Here we have shown that CSR-1, an essential AGO pro-
tein, is required, directly or indirectly, for chromosome
segregation in C. elegans. In addition CSR-1 appears to
contribute to germline RNAi. Expression of CSR-1 in the
muscle failed to rescue the secondary-AGO defect in
our assays, raising the possibility that CSR-1 functions
at yet another step in the RNAi pathway or requires spe-Ccific cofactors that are not present in muscle cells. One in-
teresting possibility is that germline RNAi has a strong
transcriptional silencing component and that CSR-1 plays
a role in mediating chromatin effects important for both
germline RNAi and chromosome segregation (model, Fig-
ure 6).
An emerging theme from this and several other recent
studies is the remarkable importance of AGO proteins
for germline maintenance and function. In C. elegans at
least four distinct groups of AGO genes are required for
fertility. These include csr-1, prg-1/prg-2, alg-1/alg-2,
and the multiple AGO mutant strain (MAGO) that includes
sago-1 and sago-2. In the mouse, all three members of the
Piwi/prg AGO family, Miwi (Deng and Lin, 2002), Mili (Kur-
amochi-Miyagawa et al., 2004), and Miwi2 (G.J. Hannon,
personal communication) are required for male fertility.
Two recent reports have shown that an abundant species
of 30 nucleotide siRNAs (named piRNAs) interacts with
Mili in meiotic spermatocytes (Aravin et al., 2006; Girard
et al., 2006). Interestingly, piRNAs accumulate asymmet-
rically in a manner analogous to the secondary and X-clus-
ter-derived siRNAs found in C. elegans. Clearly, there is
still much to learn about the production and function of
small RNAs. The paradigms of sequential AGO action
and of intersection between AGO-mediated silencing
pathways are likely to be important for understanding
the diversity and complexity of RNAi-related mechanisms
in numerous organisms.
EXPERIMENTAL PROCEDURES
Worm Strains
The Bristol strain N2 was used as the standard wild-type strain. The
AGO alleles and strains used in this study are described in the text
and are listed in Table S1. Additional alleles used in this study are
rrf-1(pk1417) I, alg-2(ok304) II, sid-1(ne328) V, and unc-22(st528) IV.
Deletions mutations were obtained as previously reported (Gengyo-
Ando and Mitani, 2000). C. elegans culture and genetics were as de-
scribed in Brenner (1974).
Rescue Experiments
For myo-3 promoter-driven expression in muscle, AGO ORFs were
cloned into pPD96.52 (from Andrew Fire). Transgenic animals were
generated by coinjection of the plasmid constructs at 10 mg/ml with
the marker plasmid pRF4 (Mello et al., 1991) at 100 mg/ml. Extrachro-
mosomal arrays were integrated by UV treatment (Evans, 2006). ergo-
1 rescued lines were generated by coinjecting a genomic PCR frag-
ment produced using forward primer ATGTTTCAAAAAAAGTTATGG
CC and reverse primer GAAAAAGAATGAATGAACTGC at a 5 mg/ml
concentration, along with the marker plasmid pTG96 (Yochem et al.,
1998) at 100 mg/ml.
RNAi Experiments
RNAi was carried out as previously reported (Fire et al., 1998; Timmons
et al., 2001). Worms were grown on NGM plates containing 1 mM IPTG
unless otherwise stated. The sequences used to generate short tan-
dem RNAi triggers, as well as the complementary 20-O-methyl affinity
matrices were the following: 50-AAG GTA TTG ATT TTA AAG AAG ATG
GAA ACA TTC TTG GAC A-30 and 50-TGT CCA AGA ATG TTT CCA TCT
TCT TTA AAA TCA ATA CCT T-30 (GFP food region 1), 50-AAG TTT GAA
GGT GAT ACC CTT GTT AAT AGA ATC GAG TTA A-30 and 50-TTA ACT
CGA TTC TAT TAA CAA GGG TAT CAC CTT CAA ACT T-30 (GFP foodell 127, 747–757, November 17, 2006 ª2006 Elsevier Inc. 755
region 2), 50-TTT CAA AGA TGA CGG GAA CTA CAA GAC ACG TGC
TGA AGT C-30 and 50-GAC TTC AGC ACG TGT CTT GTA GTT CCC
GTC ATC TTT GAA A;30 (GFP food region 3), 50-GGA TAT GTC GTT
GAA CGT TTT GAG AAG AGA GGT GGC GGT G-30 and 50-CAC
CGC CAC CTC TCT TCT CAA AAC GTT CAA CGA CAT ATC C-30
(for unc-22 RNAi trigger). The nonspecific 20-O-methyl oligonucleotide
had the following sequence: 50-CAU CAC GUA CGC GGA AUA CUU
CGA AAU GUC-30. The 20-O-methyl-modified RNA oligonucleotides
were obtained from Integrated DNA Technologies. Biotin was attached
to the 50 end of the modified oligonucleotides via a six-carbon spacer
arm.
Biochemistry and Molecular Biology
Protein and RNA purifications were performed as previously described
(Duchaine et al., 2006). Western blot analysis, immunoprecipitation of
GFP-tagged protein complexes, as well as 20-O-methyl oligonucleo-
tide affinity matrix studies were performed as reported in Hutvagner
et al. (2004). To remove nonspecific 20-O-methyl oligonucleotide inter-
actors, the clarified worm lysate was preincubated for 45 min with an
unrelated 20-O-methyl oligonucleotide.
Antibodies used in this study are as follows: (1) monoclonal HRP
conjugated anti-HA (Roche), (2) an affinity-purified polyclonal anti-
RDE-1 antibody, or (3) full-length A.v. Polyclonal Antibody (BD Biosci-
ence). Images were collected on a LAS-3000 Intelligent Dark-Box (Fu-
jifilm). Northern blot analysis was performed as described in Duchaine
et al. (2006).
Imaging and Video Microscopy
DIC and fluorescence images were collected as reported in Duchaine
et al. (2006).
Supplemental Data
Supplemental Data include one table and three figures and can be
found with this article online at http://www.cell.com/cgi/content/full/
127/4/747/DC1/.
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